BRIEF published on 06/13/2025 at 01:05, 10 months 26 days ago BioNxt Solutions Updates on Management Cease Trade Order Status Financial Statements Regulatory Compliance Audit Completion MCTO Update BioNxt Solutions
BRIEF published on 06/13/2025 at 01:05, 10 months 26 days ago BioNxt Solutions met à jour le statut de l'ordonnance de cessation d'opérations de la direction États Financiers Conformité Réglementaire Achèvement De L'audit Solutions BioNxt Mise À Jour Du MCTO
PRESS RELEASE published on 06/13/2025 at 01:00, 10 months 26 days ago BioNxt Solutions Provides Bi-Weekly MCTO Status Report BioNxt Solutions provides an update on the management cease trade order from BCSC, ensuring efforts to file required financial documents by June 30, 2025 Management Cease Trade Order BCSC Filing Deadline Financial Documents BioNxt Solutions
BRIEF published on 05/30/2025 at 01:05, 11 months 10 days ago BioNxt Solutions Updates on Management Cease Trade Order Status MCTO Financial Filing BCSC BioNxt Solutions Audit Progress
BRIEF published on 05/30/2025 at 01:05, 11 months 10 days ago BioNxt Solutions met à jour le statut de l'ordonnance de cessation d'opérations de la direction MCTO BCSC Solutions BioNxt Dépôt De Documents Financiers Progression De L'audit
PRESS RELEASE published on 05/30/2025 at 01:00, 11 months 10 days ago BioNxt Solutions Provides Bi-weekly MCTO Status Report BioNxt Solutions Inc. announces management cease trade order by BCSC until required financial statements are filed. Company's progress on compliance and commitment to regulation outlined Financial Statements Regulatory Compliance Management Cease Trade Order BCSC BioNxt Solutions Inc.
BRIEF published on 05/23/2025 at 09:10, 11 months 16 days ago BioNxt Solutions Set to Receive European Patent for Drug Delivery System Drug Development Multiple Sclerosis European Patent BioNxt Solutions Sublingual Delivery
BRIEF published on 05/23/2025 at 09:10, 11 months 16 days ago BioNxt Solutions s'apprête à obtenir un brevet européen pour son système d'administration de médicaments Sclérose En Plaques Développement De Médicaments Solutions BioNxt Brevet Européen Administration Sublinguale
PRESS RELEASE published on 05/23/2025 at 09:05, 11 months 16 days ago BioNxt Solutions Reports Formal Notice from the European Patent Office of Intention to Grant Patent BioNxt Solutions Inc. announces European Patent Office's intention to grant their core patent for advanced drug delivery systems, focusing on sublingual anticancer treatments BioNxt Solutions Inc. European Patent Office Drug Delivery Systems Sublingual Anticancer Treatments
BRIEF published on 05/16/2025 at 01:35, 11 months 24 days ago BioNxt Solutions Provides MCTO Status Update Financial Statements Regulatory Compliance Shareholder Information MCTO Audit Process
Published on 05/09/2026 at 01:30, 5 hours 32 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 7 hours 2 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 10 hours 24 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 11 hours 49 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 12 hours ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 11 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 11 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 11 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 11 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 12 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
